Development

Articles

The company will provide the first FlexFactory manufacturing platform for cell therapy manufacturing.

GE Healthcare Equips China Cell Therapy Manufacturing Plant with FlexFactory

GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.

GE and CCRM Partner with DiscGenics on New Cell Therapy

The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.

GE Speeds Up Production of Viral Vector-Based Therapeutics

GE Healthcare will equip Cellular Biomedicine Group's cell therapy manufacturing facility in Shanghai, China, with its FlexFactory single-use platform, designed to speed up cell therapy manufacturing timelines.

GE Healthcare to Equip Cell Therapy Manufacturing Facility with Single-Use Platform

Eli Lilly was awarded the 2017 FOYA Overall Winner for its continuous direct compression manufacturing installation projects.

Eli Lilly Wins 2017 Facility of the Year Award

Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.

Testing and Simulation Approaches for Single-Use Bioreactor Scale-up

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Continuous twin-screw granulation offers several options for increasing production scale. Thermo Fisher Scientific explains factors to consider in scale-up projects for manufacturing oral solid-dosage drugs. 

Scaling Up a Continuous Granulation Process

Agnes Shanley is senior editor of Pharmaceutical Technology.

Pharma’s test of continuous manufacturing is starting with oral solid-dosage forms.

21st-Century OSDs: Times, They Are a Changin’

Yueer Shi is group leader, Bristol Myers Squibb, USA, yueer.shi@bms.com

Nicola Hulme is a senior research scientist, Bristol Myers Squibb, UK, nicola.hulme@bms.com

Kieran O’Connor is Analytical Science and Technology senior chemist at SK biotek, Ireland, kieran.oconnor@sk.com. (formerly Bristol Myers Squibb)

The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.

Covalidation Strategies to Accelerate Analytical Method Transfer for Breakthrough Therapies

Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.

Scale Up